Neuron specific metabolic adaptations following multi-day exposures to oxygen glucose deprivation

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 11, 2010, Pages 1095-1104

  Zeiger, Stephanie L H ^a,b,c   McKenzie, Jennifer R ^a   Stankowski, Jeannette N ^b,c   Martin, Jacob A ^a   Cliffel, David E ^a   McLaughlin, BethAnn ^a,c  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ATP; Caspase activation; Heat shock protein 70; Microphysiometry; Oxygen glucose deprivation; Preconditioning; Protein carbonyl formation; Reactive oxygen species

Indexed keywords

CASPASE; GLUCOSE; HEAT SHOCK PROTEIN 70; LACTIC ACID; OXYGEN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; EMBRYO; ENZYME ACTIVATION; ISCHEMIC PRECONDITIONING; NEUROPROTECTION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SECRETION; RAT; STROKE; TRANSIENT ISCHEMIC ATTACK;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BLOTTING, WESTERN; CASPASE 3; CELL HYPOXIA; CELLS, CULTURED; ENERGY METABOLISM; ENZYME ACTIVATION; GLUCOSE; HSP70 HEAT-SHOCK PROTEINS; IMMUNOHISTOCHEMISTRY; NEURONS; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; STRESS, PHYSIOLOGICAL; TIME FACTORS;

EID: 77956702960     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.07.013     Document Type: Article

References (83)

1. Flynn R.W., MacWalter R.S., Doney A.S. The cost of cerebral ischaemia. Neuropharmacology 2008, 55:250-256.
2. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., Hailpern S.M., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C., Roger V., Sorlie P., Steinberger J., Thom T., Wilson M., Hong Y. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117:e25-e146.
3. Chavez J.C., Hurko O., Barone F.C., Feuerstein G.Z. Pharmacologic interventions for stroke looking beyond the thrombolysis time window into the penumbra with biomarkers, not a stopwatch. Stroke 2009, 40:E558-E563.
4. Dahl N.A., Balfour W.M. Prolonged anoxic survival due to anoxia pre-exposure: brain atp, lactate, and pyruvate. Am. J. Physiol. 1964, 207:452-456.
5. Yenari M.A. Heat shock proteins and neuroprotection. Adv. Exp. Med. Biol. 2002, 513:281-299.
6. Sharp F.R., Sagar S.M. Alterations in gene expression as an index of neuronal injury: heat shock and the immediate early gene response. Neurotoxicology 1994, 15:51-59.
7. Simon H.U., Haj-Yehia A., Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000, 5:415.
8. M.A. Perez-Pinzon, Role of reactive oxygen species on ischemic tolerance in the brain, in, 2005.
9. McLaughlin B.A., Hartnett K.A., Erhardt J.A., Legos J.J., White R.F., Barone F.C., Aizenman E. Caspase 3 activation is essential for neuroprotection in ischemic preconditioning. Proc. Natl Acad. Sci. U. S. A. 2003, 100:715-720.
10. Schurr A., Reid K.H., Tseng M.T., West C., Rigor B.M. Adaptation of adult brain tissue to anoxia and hypoxia in vitro. Brain Res. 1986, 374:244-248.
11. Perez-Pinzon M.A., Xu G.P., Dietrich W.D., Rosenthal M., Sick T.J. Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7days of reperfusion following global cerebral ischemia. J. Cereb. Blood Flow Metab. 1997, 17:175-182.
12. Stenzel-Poore M.P., Stevens S.L., King J.S., Simon R.P. Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis. Stroke 2007, 38:680-685.
13. Dhodda V.K., Sailor K.A., Bowen K.K., Vemuganti R. Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J. Neurochem. 2004, 89:73-89.
14. Dirnagl U., Meisel A. Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning?. Neuropharmacology 2008, 55:334-344.
15. Gidday J.M. Cerebral preconditioning and ischaemic tolerance. Nat. Rev. Neurosci. 2006, 7:437-448.
16. Mayanagi K., Gaspar T., Katakam P.V., Kis B., Busija D.W. The mitochondrial K(ATP) channel opener BMS-191095 reduces neuronal damage after transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 2007, 27:348-355.
17. Sandu N., Cornelius J., Filis A., Arasho B., Perez-Pinzon M., Schaller B. Ischemic tolerance in stroke treatment. Expert Rev. Cardiovasc. Ther. 2009, 7:1255-1261.
18. Deplanque D., Masse I., Lefebvre C., Libersa C., Leys D., Bordet R. Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity. Neurology 2006, 67:1403-1410.
19. Moncayo J., de Freitas G.R., Bogousslavsky J., Altieri M., van Melle G. Do transient ischemic attacks have a neuroprotective effect?. Neurology 2000, 54:2089-2094.
20. Albers G.W., Caplan L.R., Easton J.D., Fayad P.B., Mohr J.P., Saver J.L., Sherman D.G. Transient ischemic attack - proposal for a new definition. N Engl J. Med. 2002, 347:1713-1716. T.I.A.W.G.
21. Lovett J.K., Dennis M.S., Sandercock P.A., Bamford J., Warlow C.P., Rothwell P.M. Very early risk of stroke after a first transient ischemic attack. Stroke 2003, 34:e138-e140.
22. Coull A.J., Lovett J.K., Rothwell P.M. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ 2004, 328:326.
23. Rothwell P.M., Giles M.F., Chandratheva A., Marquardt L., Geraghty O., Redgrave J.N., Lovelock C.E., Binney L.E., Bull L.M., Cuthbertson F.C., Welch S.J., Bosch S., Alexander F.C., Silver L.E., Gutnikov S.A., Mehta Z. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007, 370:1432-1442.
24. Weih M., Kallenberg K., Bergk A., Dirnagl U., Harms L., Wernecke K.D., Einhaupl K.M. Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain?. Stroke 1999, 30:1851-1854.
25. Wegener S., Gottschalk B., Jovanovic V., Knab R., Fiebach J.B., Schellinger P.D., Kucinski T., Jungehulsing G.J., Brunecker P., Muller B., Banasik A., Amberger N., Wernecke K.D., Siebler M., Rother J., Villringer A., Weih M. Transient ischemic attacks before ischemic stroke: Preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke 2004, 35:616-621.
26. Moncayo J., de Freitas G.R., Bogousslavsky J., Altieri M., van Melle G. Do transient ischemic attacks have a neuroprotective effect?. Neurology 2000, 54:2089-2094.
27. Schaller B. Ischemic preconditioning as induction of ischemic tolerance after transient ischemic attacks in human brain: its clinical relevance. Neurosci. Lett. 2005, 377:206-211.
28. Johnston S.C. Ischemic preconditioning from transient ischemic attacks?: data from the Northern California TIA study. Stroke 2004, 35:2680-2682.
29. Granfeldt A., Lefer D.J., Vinten-Johansen J. Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc. Res. 2009, 83:234-246.
30. Das D.K., Engelman R.M., Maulik N. Oxygen free radical signaling in ischemic preconditioning. Ann. NY Acad. Sci. 1999, 874:49-65.
31. Aoki M., Abe K., Kawagoe J., Nakamura S., Kogure K. The preconditioned hippocampus accelerates HSP70 heat shock gene expression following transient ischemia in the gerbil. Neurosci. Lett. 1993, 155:7-10.
32. Pringle A.K., Angunawela R., Wilde G.J., Mepham J.A., Sundstrom L.E., Iannotti F. Induction of 72kDa heat-shock protein following sub-lethal oxygen deprivation in organotypic hippocampal slice cultures. Neuropathol. Appl. Neurobiol. 1997, 23:289-298.
33. Cohen M.V., Baines C.P., Downey J.M. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu. Rev. Physiol. 2000, 62:79-109.
34. Currie R.W., Ellison J.A., White R.F., Feuerstein G.Z., Wang X., Barone F.C. Benign focal ischemic preconditioning induces neuronal Hsp70 and prolonged astrogliosis with expression of Hsp27. Brain Res. 2000, 863:169-181.
35. Brown J.E., Zeiger S.L.H., Hettinger J.C., Brooks J.D., Holt B., Morrow J.D., Musiek E.S., Milne G., McLaughlin B. Essential role of the redox-sensitive kinase p66shc in determining energetic and oxidative status and cell fate in neuronal preconditioning. J. Neurosci. 2010, 30:5242-5252.
36. McLaughlin B.A., Nelson D., Silver I.A., Erecinska M., Chesselet M.F. Methylmalonate toxicity in primary neuronal cultures. Neuroscience 1998, 86:279-290.
37. Chen Y., Stevens B., Chang J., Milbrandt J., Barres B.A., Hell J.W. NS21: re-defined and modified supplement B27 for neuronal cultures. J. Neurosci. Methods 2008, 171:239-247.
38. Zeiger S.L., Musiek E.S., Zanoni G., Vidari G., Morrow J.D., Milne G.J., McLaughlin B. Neurotoxic lipid peroxidation species formed by ischemic stroke increase injury. Free Radic. Biol. Med. 2009, 47:1422-1431.
39. Musiek E.S., Breeding R.S., Milne G.L., Zanoni G., Morrow J.D., McLaughlin B.A. Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration. J. Neurochem. 2006, 97:1301-1313.
40. Eklund S.E.C., D.E., Kozlov E., Prokop A., Wikswo J., Baudenbacher F. Modification of the Cytosensor microphysiometer to simultaneously measure extracellular acidification and oxygen consumption rates. Anal. Chim. Acta 2003, 496:93-101.
41. Eklund S.E., Kozlov E., Taylor D.E., Baudenbacher F., Cliffel D.E. Real-time cell dynamics with a multianalyte physiometer. Methods Mol. Biol. 2005, 303:209-223.
42. Eklund S.E., Snider R.M., Wikswo J., Baudenbacher F., Prokop A., Cliffel D.E. Multianalyte microphysiometry as a tool in metabolomics and systems biology. J. Electroanal. Chem. 2006, 587:333.
43. Eklund S.E., Taylor D., Kozlov E., Prokop A., Cliffel D.E. A microphysiometer for simultaneous measurement of changes in extracellular glucose, lactate, oxygen, and acidification rate. Anal. Chem. 2004, 76:519-527.
44. Walder B., Lauber R., Zbinden A.M. Accuracy and cross-sensitivity of 10 different anesthetic gas monitors. J. Clin. Monit. 1993, 9:364-373.
45. Ravagnan L., Gurbuxani S., Susin S.A., Maisse C., Daugas E., Zamzami N., Mak T., Jaattela M., Penninger J.M., Garrido C., Kroemer G. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat. Cell Biol. 2001, 3:839-843.
46. Nuttall M.E., Lee D., McLaughlin B., Erhardt J.A. Selective inhibitors of apoptotic caspases: implications for novel therapeutic strategies. Drug Discov. Today 2001, 6:85.
47. O'Duffy A.E., Bordelon Y.M., McLaughlin B. Killer proteases and little strokes-how the things that do not kill you make you stronger. J. Cereb Blood Flow Metab. 2006.
48. Vanden Hoek T.L., Becker L.B., Shao Z., Li C., Schumacker P.T. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J. Biol. Chem. 1998, 273:18092-18098.
49. Brown I.R. Heat shock proteins and protection of the nervous system. Ann. NY Acad. Sci. 2007, 1113:147-158.
50. Robinson M.B., Tidwell J.L., Gould T., Taylor A.R., Newbern J.M., Graves J., Tytell M., Milligan C.E. Extracellular heat shock protein 70: a critical component for motoneuron survival. J. Neurosci. 2005, 25:9735-9745.
51. Houenou L.J., Li L., Lei M., Kent C.R., Tytell M. Exogenous heat shock cognate protein Hsc 70 prevents axotomy-induced death of spinal sensory neurons. Cell Stress Chaperones 1996, 1:161-166.
52. Tidwell J.L., Houenou L.J., Tytell M. Administration of Hsp70 in vivo inhibits motor and sensory neuron degeneration. Cell Stress Chaperones 2004, 9:88-98.
53. Novoselova T.V., Margulis B.A., Novoselov S.S., Sapozhnikov A.M., van der Spuy J., Cheetham M.E., Guzhova I.V. Treatment with extracellular HSP70/HSC70 protein can reduce polyglutamine toxicity and aggregation. J. Neurochem. 2005, 94:597-606.
54. Taylor A.R., Robinson M.B., Gifondorwa D.J., Tytell M., Milligan C.E. Regulation of heat shock protein 70 release in astrocytes: role of signaling kinases. Dev. Neurobiol. 2007, 67:1815-1829.
55. Vega V.L., Rodriguez-Silva M., Frey T., Gehrmann M., Diaz J.C., Steinem C., Multhoff G., Arispe N., De Maio A. Hsp70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages. J. Immunol. 2008, 180:4299-4307.
56. Broquet A.H., Thomas G., Masliah J., Trugnan G., Bachelet M. Expression of the molecular chaperone Hsp70 in detergent-resistant microdomains correlates with its membrane delivery and release. J. Biol. Chem. 2003, 278:21601-21606.
57. Lancaster G.I., Febbraio M.A. Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins. J. Biol. Chem. 2005, 280:23349-23355.
58. Eklund S.E.S., R.M., Wikswo J.P., Baudenbacher F.J., Prokop A., Cliffel D.E. Multianalyte Microphysiometry as a tool in metabolomics and systems biology. J. Electroanal. Chem. 2006, 587:333-339.
59. Zhu Y., Zhang Y., Ojwang B.A., Brantley M.A., Gidday J.M. Long-term tolerance to retinal ischemia by repetitive hypoxic preconditioning: role of HIF-1alpha and heme oxygenase-1. Invest Ophthalmol. Vis. Sci. 2007, 48:1735-1743.
60. Della Morte D., Abete P., Gallucci F., Scaglione A., D'Ambrosio D., Gargiulo G., De Rosa G., Dave K.R., Lin H.W., Cacciatore F., Mazzella F., Uomo G., Rundek T., Perez-Pinzon M.A., Rengo F. Transient ischemic attack before nonlacunar ischemic stroke in the elderly. J. Stroke Cerebrovasc. Dis. 2008, 17:257-262.
61. Brown I.R. Heat shock proteins and protection of the nervous system. Ann. NY Acad. Sci. 2007, 1113:147-158.
62. Calderwood S.K., Mambula S.S., Gray P.J. Extracellular heat shock proteins in cell signaling and immunity. Ann. NY Acad. Sci. 2007, 1113:28-39.
63. Fauconneau B., Petegnief V., Sanfeliu C., Piriou A., Planas A.M. Induction of heat shock proteins (HSPs) by sodium arsenite in cultured astrocytes and reduction of hydrogen peroxide-induced cell death. J. Neurochem. 2002, 83:1338-1348.
64. Graner M.W., Cumming R.I., Bigner D.D. The heat shock response and chaperones/heat shock proteins in brain tumors: surface expression, release, and possible immune consequences. J. Neurosci. 2007, 27:11214-11227.
65. Graner M.W., Raynes D.A., Bigner D.D., Guerriero V. Heat shock protein 70-binding protein 1 is highly expressed in high-grade gliomas, interacts with multiple heat shock protein 70 family members, and specifically binds brain tumor cell surfaces. Cancer Sci. 2009, 100:1870-1879.
66. Gross C., Koelch W., DeMaio A., Arispe N., Multhoff G. Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific binding and uptake of granzyme B. J. Biol. Chem. 2003, 278:41173-41181.
67. Robinson M.B., Tidwell J.L., Gould T., Taylor A.R., Newbern J.M., Graves J., Tytell M., Milligan C.E. Extracellular heat shock protein 70: a critical component for motoneuron survival. J. Neurosci. 2005, 25:9735-9745.
68. Thériault J.R., Mambula S.S., Sawamura T., Stevenson M.A., Calderwood S.K. Extracellular HSP70 binding to surface receptors present on antigen presenting cells and endothelial/epithelial cells. FEBS Lett. 2005, 579:1951-1960.
69. Anand P.K., Anand E., Bleck C.K.E., Anes E., Griffiths G. Exosomal Hsp70 induces a pro-inflammatory response to foreign particles including mycobacteria. PLoS ONE 2010, 5:e10136.
70. Kim H.P., Morse D., Choi A.M.K. Heat-shock proteins: new keys to the development of cytoprotective therapies. Expert Opin. Ther. Targets 2006, 10:759-769.
71. Luo H.R., Hattori H., Hossain M.A., Hester L., Huang Y., Lee-Kwon W., Donowitz M., Nagata E., Snyder S.H. Akt as a mediator of cell death. PNAS 2003, 100:11712-11717.
72. Zhang Y., Park T.S., Gidday J.M. Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H2573-H2581.
73. Wick A., Wick W., Waltenberger J., Weller M., Dichgans J., Schulz J.B. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J. Neurosci. 2002, 22:6401-6407.
74. Houenou L.J., Li L., Lei M., Kent C.R., Tytell M. Exogenous heat shock cognate protein Hsc 70 prevents axotomy-induced death of spinal sensory neurons. Cell Stress Chaperones 1996, 1:161-166.
75. Tidwell J.L., Houenou L.J., Tytell M. Administration of Hsp70 in vivo inhibits motor and sensory neuron degeneration. Cell Stress Chaperones 2004, 9:88-98.
76. Chiba S., Yokota S., Yonekura K., Tanaka S., Furuyama H., Kubota H., Fujii N., Matsumoto H. Autoantibodies against HSP70 family proteins were detected in the cerebrospinal fluid from patients with multiple sclerosis. J. Neurol. Sci. 2006, 241:39-43.
77. Hecker J.G., Sundram H., Zou S., Praestgaard A., Bavaria J.E., Ramchandren S., McGarvey M. Heat shock proteins HSP70 and HSP27 in the cerebral spinal fluid of patients undergoing thoracic aneurysm repair correlate with the probability of postoperative paralysis. Cell Stress Chaperones 2008, 13:435-446.
78. Tang D., Kang R., Cao L., Zhang G., Yu Y., Xiao W., Wang H., Xiao X. A pilot study to detect high mobility group box 1 and heat shock protein 72 in cerebrospinal fluid of pediatric patients with meningitis. Crit. Care Med. 2008, 36:291-295.
79. Zhang X., Xu Z., Zhou L., Chen Y., He M., Cheng L., Hu F.B., Tanguay R.M., Wu T. Plasma levels of Hsp70 and anti-Hsp70 antibody predict risk of acute coronary syndrome. Cell Stress Chaperones 2010.
80. Zhan X., Ander B.P., Jickling G., Turner R., Stamova B., Xu H., Liu D., Davis R.R., Sharp F.R. Brief focal cerebral ischemia that simulates transient ischemic attacks in humans regulates gene expression in rat peripheral blood. J. Cereb Blood Flow Metab. 2009.
81. Calanchini P.R., Swanson P.D., Gotshall R.A., Haerer A.F., Poskanzer D.C., Price T.R., Conneally P.M., Dyken M.L., Futty D.E. Cooperative study of hospital frequency and character of transient ischemic attacks. IV. The reliability of diagnosis. JAMA 1977, 238:2029-2033.
82. Landi G. Clinical-diagnosis of transient ischemic attacks. Lancet 1992, 339:402-405.
83. Johnston S.C., Gress D.R., Browner W.S., Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000, 284:2901-2906.